Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.36 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 2/20 | 0.34 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.34 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.34 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.34 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.34 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.34 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.34 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.34 |
| ▸ | NOS3 | P29474 | 1/20 | 0.34 |
| ▸ | NOS2 | P35228 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6950879 | 1.00 | CYP3A4 (0.37) | CYP3A4CYP1A2CYP2D6CYP2C9NFKB1 | |
| SCHEMBL6954465 | 1.00 | CYP3A4 (0.37) | CYP3A4CYP1A2CYP2D6CYP2C9NFKB1 | |
| SCHEMBL27919760 | 0.83 | SLC7A5 (0.38) | CYP2D6NOS1NOS3NOS2CA12 | |
| SCHEMBL977470 | 0.83 | SLC7A5 (0.38) | CYP2D6NOS1NOS3NOS2CA12 | |
| SCHEMBL29104750 | 0.83 | ELANE (0.32) | NOS1NOS3NOS2ELANEDGAT1 | |
| SCHEMBL10662683 | 0.82 | NOS1 (0.35) | NOS1NOS3NOS2CA12CA14 | |
| SCHEMBL10659347 | 0.82 | NOS1 (0.35) | NOS1NOS3NOS2CA12CA14 | |
| SCHEMBL206710 | 0.81 | CYP3A4 (0.44) | CYP3A4CYP1A2CYP2D6CYP2C9NFKB1 | |
| SCHEMBL3297 | 0.81 | CYP3A4 (0.44) | CYP3A4CYP1A2CYP2D6CYP2C9NFKB1 | |
| SCHEMBL320243 | 0.81 | CYP3A4 (0.44) | CYP3A4CYP1A2CYP2D6CYP2C9NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118307534-A | LTA4H inhibitors and uses thereof | 上海海雁医药科技有限公司 | 2024-07-09 | — | — | CN | disclosed |
| EP-4392417-A1 | KINASE MODULATORS, COMPOSITIONS COMPRISING THE KINASE MODULATOR, AND METHODS OF USING THE SAME | BIOFRONT LTD (KY) | 2024-07-03 | — | — | EP | disclosed |
| EP-4366777-A2 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | PROFOUNDBIO US CO. (US) | 2024-05-15 | — | — | EP | disclosed |
| WO-2023226965-A1 | ROCK INHIBITORS AND USES THEREOF | DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. (CN) | 2023-11-30 | — | — | WO | disclosed |
| EP-4244221-A1 | PRODRUG OF PYRROLIDONE DERIVATIVES AS GLUCOKINASE ACTIVATOR | Hua Medicine (Shanghai) Ltd. (CN) | 2023-09-20 | — | — | EP | disclosed |
| WO-2023040937-A1 | PRODRUG OF PYRROLIDONE DERIVATIVES AS GLUCOKINASE ACTIVATOR | HUA MEDICINE (SHANGHAI) LTD. (CN) | 2023-03-23 | — | — | WO | disclosed |
| WO-2023025092-A1 | KINASE MODULATORS, COMPOSITIONS COMPRISING THE KINASE MODULATOR, AND METHODS OF USING THE SAME | BIOFRONT LTD (CAYMAN) (KY) | 2023-03-02 | — | — | WO | disclosed |
| WO-2023280227-A2 | LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME | PROFOUNDBIO US CO. (US) | 2023-01-12 | — | — | WO | disclosed |
| CN-107660202-B | Water-soluble prodrugs | 大日本住友制药肿瘤公司 | 2021-12-24 | — | — | CN | disclosed |
| EP-3917936-A1 | ALKYLBORONIC ACIDS AS ARGINASE INHIBITORS | Guangdong Newopp Biopharmaceuticals Co., Ltd. (CN) | 2021-12-08 | — | — | EP | disclosed |
| WO-2018149419-A1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | RQX PHARMACEUTICALS, INC. (US) | 2018-08-23 | — | — | WO | disclosed |
| EP-2509942-A2 | BIS-ACYLATED HYDROXYLAMINE DERIVATIVES | Johns Hopkins University (US) | 2012-10-17 | — | — | EP | disclosed |
| EP-2509941-A2 | N-ACYLATED HYDROXYLAMINE DERIVATIVES AND O-ACYLATED HYDROXYLAMINE DERIVATIVES | The Johns Hopkins University (US) | 2012-10-17 | — | — | EP | disclosed |
| WO-2011071947-A2 | BIS-ACYLATED HYDROXYLAMINE DERIVATIVES | JOHNS HOPKINS UNIVERSITY (US) | 2011-06-16 | — | — | WO | disclosed |
| WO-2011071951-A2 | N-ACYLOXYSULFONAMIDE AND N-HYDROXY-N-ACYLSULFONAMIDE DERIVATIVES | JOHNS HOPKINS UNIVERSITY (US) | 2011-06-16 | — | — | WO | disclosed |
| CN-100584842-C | Thiazole derivative | TAISHO PHARMACEUTICAL CO LTD | 2010-01-27 | — | — | CN | disclosed |
| CN-1960975-A | Substituted pyridones as poly (ADP-ribose) polymerase (PARP) inhibitors | AVENTIS PHARMA INC (US) | 2007-05-09 | — | — | CN | disclosed |
| CN-1956979-A | Thiazole derivatives | TAISHO PHARMACEUTICAL CO LTD (JP) | 2007-05-02 | — | — | CN | disclosed |
| EP-0595183-B1 | Hydantoin derivatives, salts thereof and maillard reaction inhibitors comprising the same | SANWA KAGAKU KENKYUSHO CO (JP) | 1999-08-25 | — | — | EP | disclosed |
| US-5883255-A | Substituted indolizino 1,2-b!quinolinones | SMITHKLINE BEECHAM CORPORATION (US) | 1999-03-16 | — | — | US | disclosed |